S&P 500   4,008.01 (-0.39%)
DOW   32,223.42 (+0.08%)
QQQ   298.44 (-1.16%)
AAPL   145.54 (-1.07%)
MSFT   261.50 (+0.15%)
FB   200.04 (+0.71%)
GOOGL   2,288.90 (-1.38%)
AMZN   2,216.21 (-1.99%)
TSLA   724.37 (-5.88%)
NVDA   172.64 (-2.50%)
BABA   86.48 (-1.72%)
NIO   14.55 (+1.68%)
AMD   94.24 (-0.93%)
CGC   5.73 (-3.21%)
MU   70.47 (-2.02%)
T   20.28 (+2.22%)
GE   74.63 (-0.56%)
F   13.05 (-3.33%)
DIS   105.18 (-2.00%)
AMC   11.71 (-0.85%)
PFE   50.67 (+1.50%)
PYPL   77.65 (-1.50%)
NFLX   186.51 (-0.60%)
S&P 500   4,008.01 (-0.39%)
DOW   32,223.42 (+0.08%)
QQQ   298.44 (-1.16%)
AAPL   145.54 (-1.07%)
MSFT   261.50 (+0.15%)
FB   200.04 (+0.71%)
GOOGL   2,288.90 (-1.38%)
AMZN   2,216.21 (-1.99%)
TSLA   724.37 (-5.88%)
NVDA   172.64 (-2.50%)
BABA   86.48 (-1.72%)
NIO   14.55 (+1.68%)
AMD   94.24 (-0.93%)
CGC   5.73 (-3.21%)
MU   70.47 (-2.02%)
T   20.28 (+2.22%)
GE   74.63 (-0.56%)
F   13.05 (-3.33%)
DIS   105.18 (-2.00%)
AMC   11.71 (-0.85%)
PFE   50.67 (+1.50%)
PYPL   77.65 (-1.50%)
NFLX   186.51 (-0.60%)
S&P 500   4,008.01 (-0.39%)
DOW   32,223.42 (+0.08%)
QQQ   298.44 (-1.16%)
AAPL   145.54 (-1.07%)
MSFT   261.50 (+0.15%)
FB   200.04 (+0.71%)
GOOGL   2,288.90 (-1.38%)
AMZN   2,216.21 (-1.99%)
TSLA   724.37 (-5.88%)
NVDA   172.64 (-2.50%)
BABA   86.48 (-1.72%)
NIO   14.55 (+1.68%)
AMD   94.24 (-0.93%)
CGC   5.73 (-3.21%)
MU   70.47 (-2.02%)
T   20.28 (+2.22%)
GE   74.63 (-0.56%)
F   13.05 (-3.33%)
DIS   105.18 (-2.00%)
AMC   11.71 (-0.85%)
PFE   50.67 (+1.50%)
PYPL   77.65 (-1.50%)
NFLX   186.51 (-0.60%)
S&P 500   4,008.01 (-0.39%)
DOW   32,223.42 (+0.08%)
QQQ   298.44 (-1.16%)
AAPL   145.54 (-1.07%)
MSFT   261.50 (+0.15%)
FB   200.04 (+0.71%)
GOOGL   2,288.90 (-1.38%)
AMZN   2,216.21 (-1.99%)
TSLA   724.37 (-5.88%)
NVDA   172.64 (-2.50%)
BABA   86.48 (-1.72%)
NIO   14.55 (+1.68%)
AMD   94.24 (-0.93%)
CGC   5.73 (-3.21%)
MU   70.47 (-2.02%)
T   20.28 (+2.22%)
GE   74.63 (-0.56%)
F   13.05 (-3.33%)
DIS   105.18 (-2.00%)
AMC   11.71 (-0.85%)
PFE   50.67 (+1.50%)
PYPL   77.65 (-1.50%)
NFLX   186.51 (-0.60%)

Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness

Tuesday, April 20, 2021 | Thomas Hughes
Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness

Undervalued Proctor & Gamble Is On Track For Growth 

Like so many other major consumer staples companies Proctor & Gamble (NYSE: PG) is supported not only by repositioning efforts but by COVID-induced trends as well. Also like other consumer staples companies, Proctor & Gamble's 2020 gains appear to be sticky and providing a foundation for growth in 2021 as well. The FQ3 earnings are not only better than expected but the company also raised its guidance reaffirming the market's expectations for the FQ4 period. What we like about this stock is that it is 1) consumer-focused 2) a staple business 3) has earnings growth on tap 4) it offers some value and 5) it is a Dividend King with a high probability of making a 66th consecutive increase in early 2022. 

Proctor & Gamble Beats And Raises, Shares Fall 

Proctor & Gamble had a decent Q3 period with revenue up 5.2% from last year and on top of last year's roughly 5.0% advance. The $18.11 billion in net consolidated revenue beat the consensus by nearly 100 basis points and comes with improved guidance as well. At the organic level, adjusted for divestiture and acquisitions, revenue grew 4.0% versus the 3.7% expected by the analysts. The Beauty and Fabric/Home segments performed the best with 7.0% growth each. The Baby & Family segment saw its revenue fall -1.0%. 

Moving down, there is evidence of mounting pressure on margins due to rising commodity costs but the company is taking measures to alleviate it. The adjusted gross margin came in at 50.7% versus the 50.9% expected by the analysts while operating margins missed as well. The good news is that margins are still in good enough shape to deliver better than expected GAAP earnings and net growth from the YOY period. Looking forward, the company announced it was planning price hikes to begin in the 3rd quarter. The hikes are targeted by brand and will run in the range of 5% to 10%. We view this as a net positive for the company although the impact of higher prices on volume sales is yet to be seen. 

Proctor & Gamble Boost Shareholder Returns 

Proctor & Gamble's Q3 and YTD results have been so strong the company is accelerating its cash return to shareholders. The company raised the dividend by 10% earlier this month and announced an increase in buybacks for this year. The company says it is targeting more than $8 billion in dividends reflecting the recent increase and upped the buyback outlook by a billion dollars or 10% for the fiscal year. Based on the company's history, balance sheet, and guidance we believe this pace should continue into the fiscal 2022 period. The bottom line, any weakness in price action will likely be met by institutional buying in the form of company buybacks. 

The Technical Outlook: Proctor & Gamble Pulls Back To Support 

Shares of Proctor & Gamble are down about 1.0% in early trading but we don't think they will stay down for long. There is already evidence of buying at the short-term moving average which is consistent with a previous resistance point. This resistance now supports level is also consistent with the baseline of a Head & Shoulders Reversal Pattern that should provide a launchpad for higher prices. There may be some more price weakness in the near term but we view it as a buying opportunity. Longer-term, this stock is going to move up and retest the recent highs before moving up to retest the 2020 highs, if not higher. 

Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness

Should you invest $1,000 in Procter & Gamble right now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Procter & Gamble (PG)
2.7653 of 5 stars
$155.12+1.0%2.35%27.07Buy$165.64
Compare These Stocks  Add These Stocks to My Watchlist 

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.